EM Systems Co., Ltd.

4820.T
Health Information Services
2026/11/13 12:49 Updated
Market Cap: $245.9M (¥39.3B)
Stock Price: $3.55 (¥567)
Exchange Rate: 1 USD = ¥159.74

Notice of Revision to Full-Year Consolidated Earnings Forecast for the Fiscal Year Ending December 2026

Revised the full-year consolidated earnings forecast for the fiscal year ending December 2026. Net sales are decreased by △1,528 million yen from the previous forecast, operating income is decreased by △1,078 million yen, ordinary income is decreased by △975 million yen, and net income attributable to owners of parent is decreased by △707 million yen. Dividends remain unchanged at an interim 5 yen, year-end 18 yen, and annual 23 yen. The reason is lower-than-expected initial sales in the Pharmacy System business and the impact of changes in resource allocation.

Importance:
Page Updated: November 14, 2026
IR Disclosure Date: November 13, 2026

Key Figures

  • Net Sales: 21,233 million yen (vs. previous forecast △1,528 million yen)
  • Operating Income: 2,238 million yen (vs. previous forecast △1,078 million yen)
  • Net Income Attributable to Owners of Parent: 1,485 million yen (vs. previous forecast △707 million yen)

AI要約

Key Points of the Results

The Company has revised its full-year consolidated earnings forecast for the fiscal year ending December 2026. Net sales are expected to decrease approximately 6.7% from the previous forecast, and operating income, ordinary income, and net income attributable to owners of parent have all been substantially revised downward. The primary causes are the tapering of welfare-administration-related demand such as online identity verification and electronic prescriptions, and the impact of suppressing in-house replacement promotion to expand future revenue base. The dividend policy itself follows the medium-term management plan, and the annual dividend of 23 yen will be maintained.

Outlook and Impact

Going forward, the effectiveness of changes in sales strategy and the reallocation of resources will be key to earnings recovery. While recurring revenue such as subscription-based billing is expected to remain steady, a shortfall in initial sales may affect overall performance. As a special item, the Company will continue to scrutinize future risk responses and also consider the impact of any extraordinary loss associated with the planned absorption-type merger of a consolidated subsidiary scheduled for January next year.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

EM Systems Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →